Defense Health Care:

Pharmacy Copayments

HEHS-99-134R: Published: Jun 8, 1999. Publicly Released: Jun 8, 1999.

Additional Materials:

Contact:

Stephen P. Backhus
(202) 512-7111
contact@gao.gov

 

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

Pursuant to a congressional request, GAO responded to concerns regarding its previous recommendations proposing that Department of Defense (DOD) pharmacy programs charge copayments for prescription drugs.

GAO noted that: (1) the recommendations in GAO's report were designed to correct serious problems in DOD's pharmacy benefit programs and at the same time enable a more flexible and richer benefit package at the lowest possible cost; (2) GAO believes that the introduction of incentive-based copayments is an essential element in the overall plan to provide stable, high-quality pharmacy benefits over the long term; and (3) Medicare-eligible retirees should be better off with a pharmacy benefit that covers the drugs they need with a reasonable copayment compared with a copayment-free benefit that does not include many of those drugs.

Oct 11, 2018

Oct 10, 2018

Oct 9, 2018

Sep 24, 2018

Sep 20, 2018

Sep 10, 2018

Sep 6, 2018

Sep 5, 2018

Sep 4, 2018

Looking for more? Browse all our products here